HAEMONETICS ($HAE) posted quarterly earnings results for Q4 2026 on Thursday, May 7th. The company reported earnings of $1.29 per share, beating estimates of $1.28 by $0.01. The company also reported revenue of $346,350,000, beating estimates of $340,230,801 by $6,119,199.
You can see Quiver Quantitative's $HAE stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
HAEMONETICS Insider Trading Activity
HAEMONETICS insiders have traded $HAE stock on the open market 1 times in the past 6 months. Of those trades, 1 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $HAE stock by insiders over the last 6 months:
- MARK W KROLL purchased 1,400 shares for an estimated $98,784
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API.
HAEMONETICS Hedge Fund Activity
We have seen 159 institutional investors add shares of HAEMONETICS stock to their portfolio, and 187 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- ARROWSTREET CAPITAL, LIMITED PARTNERSHIP added 1,254,035 shares (+994.7%) to their portfolio in Q4 2025, for an estimated $100,510,905
- HOLOCENE ADVISORS, LP added 1,225,351 shares (+3148.4%) to their portfolio in Q4 2025, for an estimated $98,211,882
- CITADEL ADVISORS LLC added 1,067,004 shares (+481.9%) to their portfolio in Q4 2025, for an estimated $85,520,370
- AQR CAPITAL MANAGEMENT LLC added 1,034,226 shares (+48.6%) to their portfolio in Q4 2025, for an estimated $82,893,213
- POINT72 ASSET MANAGEMENT, L.P. added 810,328 shares (+1882.3%) to their portfolio in Q4 2025, for an estimated $64,947,789
- NORTH PEAK CAPITAL MANAGEMENT, LLC added 740,626 shares (+204.4%) to their portfolio in Q4 2025, for an estimated $59,361,173
- MILLENNIUM MANAGEMENT LLC removed 718,358 shares (-92.9%) from their portfolio in Q4 2025, for an estimated $57,576,393
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API.
HAEMONETICS Government Contracts
We have seen $267,956 of award payments to $HAE over the last year.
Here are some of the awards which we have have seen pay out the most over the last year:
- EXPRESS REPORT: EXPRESS REPORT: NX ORDERS PLACED DURING THE MONTHS OF JAN-MAY 2025.: $22,660
- (R) HAEMONETICS CORPORATION:1177264 [25-002935] AUTOMATED CELL PROCESSORS ACP 215 SERIAL NUMBER 19C027SPG ...: $12,166
- TEG ANALYZERS: $8,148
To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.
HAEMONETICS Analyst Ratings
Wall Street analysts have issued reports on $HAE in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- BTIG issued a "Buy" rating on 02/06/2026
- Mizuho issued a "Outperform" rating on 12/17/2025
To track analyst ratings and price targets for HAEMONETICS, check out Quiver Quantitative's $HAE forecast page.
HAEMONETICS Price Targets
Multiple analysts have issued price targets for $HAE recently. We have seen 6 analysts offer price targets for $HAE in the last 6 months, with a median target of $81.0.
Here are some recent targets:
- Anthony Petrone from Mizuho set a target price of $70.0 on 04/13/2026
- Joanne Wuensch from Citigroup set a target price of $70.0 on 03/11/2026
- Marie Thibault from BTIG set a target price of $88.0 on 02/06/2026
- Michael Petusky from Barrington Research set a target price of $94.0 on 02/06/2026
- David Rescott from Baird set a target price of $99.0 on 12/15/2025
- Rohin Patel from JP Morgan set a target price of $74.0 on 12/12/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
Check out the Quiver Quantitative API to build on top of data on congressional stock trading, insider transactions, hedge fund moves, and more.
